byUniversity of BirminghamBaby wearing EEG cap for the study. Pictured with parent. Credit: University of Birmingham.Babies as young as four months old can make sense of how their bodies interac
byUniversity of BirminghamBaby wearing EEG cap for the study. Pictured with parent. Credit: University of Birmingham.Babies as young as four months old can make sense of how their bodies interac
byOsaka UniversityActivation of the claustrum, identified as a reliable marker of the stressed brain, controls stress-induced anxiety-like and depression-like behaviors. Credit: Atsushi KasaiIt
byOsaka UniversityActivation of the claustrum, identified as a reliable marker of the stressed brain, controls stress-induced anxiety-like and depression-like behaviors. Credit: Atsushi KasaiIt
FEBRUARY 15, 2024by Elana GotkineFor patients with relapsing multiple sclerosis, the anti-CD40L monoclonal antibody frexalimab has a favorable effect on the number of new gadolinium-enhancing T1-weigh
FEBRUARY 15, 2024by Elana GotkineFor patients with relapsing multiple sclerosis, the anti-CD40L monoclonal antibody frexalimab has a favorable effect on the number of new gadolinium-enhancing T1-weigh
by Lynne A Barker and Caroline Jordan,The ConversationCredit: AI-generated imageWithin our body and on our skin, trillions of bacteria and viruses exist as part of complex ecosystems called micr
by Lynne A Barker and Caroline Jordan,The ConversationCredit: AI-generated imageWithin our body and on our skin, trillions of bacteria and viruses exist as part of complex ecosystems called micr
(HealthDay)—The first human clinical trial of a nasal vaccine to slow the progression of Alzheimer's disease is set to begin after nearly 20 years of research.This is a "remarkable milestone,
(HealthDay)—The first human clinical trial of a nasal vaccine to slow the progression of Alzheimer's disease is set to begin after nearly 20 years of research.This is a "remarkable milestone,
by University of California, Los AngelesCredit: CC0 Public DomainA new stem cell-based treatment for progressive dementia just took a big step closer to the clinic.UCLA researchers have successfu
by University of California, Los AngelesCredit: CC0 Public DomainA new stem cell-based treatment for progressive dementia just took a big step closer to the clinic.UCLA researchers have successfu
by Lynda De Widt,Mayo ClinicCredit: Anna Shvets from PexelsMayo Clinic researchers have identified new scoring criteria allowing for the detection of treatable forms of rapidly progressive demen
by Lynda De Widt,Mayo ClinicCredit: Anna Shvets from PexelsMayo Clinic researchers have identified new scoring criteria allowing for the detection of treatable forms of rapidly progressive demen
by Mallory Locklear,Yale UniversityCredit: Pixabay/CC0 Public DomainUnderstanding the link between brain activity and behavior is among the core interests of neuroscience. Having a better grasp
by Mallory Locklear,Yale UniversityCredit: Pixabay/CC0 Public DomainUnderstanding the link between brain activity and behavior is among the core interests of neuroscience. Having a better grasp
byPrinceton UniversityNeurons in the microscopic worm C. elegans. The worm’s neurons have been genetically engineered to be color coded by their cell type. The names of each neuron are shown in
byPrinceton UniversityNeurons in the microscopic worm C. elegans. The worm’s neurons have been genetically engineered to be color coded by their cell type. The names of each neuron are shown in
by University of California - RiversideTyler Lambeth (left) and Ryan Julian in the lab. Credit: Julian lab, UC RiversideAlzheimer's disease, the most common cause of dementia among the elderl
by University of California - RiversideTyler Lambeth (left) and Ryan Julian in the lab. Credit: Julian lab, UC RiversideAlzheimer's disease, the most common cause of dementia among the elderl